Picture of Bio Solution Co logo

086820 Bio Solution Co Cashflow Statement

0.000.00%
kr flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapSucker Stock

Annual cashflow statement for Bio Solution Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:Annual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited Accounts
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-1,685-8,087-1,249-11,928273
Depreciation
Amortisation
Non-Cash Items1983,503-2,7137,780-3,405
Unusual Items
Purchased R&D
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital-197-1,3293,471-45.3-357
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities83.3-3,8142,160-2,286-1,312
Capital Expenditures-663-4,085-1,159-1,228-732
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-16,535-8,072-8,53225,4801,685
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities-17,199-12,157-9,69024,252954
Financing Cash Flow Items1,2991,046517150-61.4
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities42,642416-442-14,702-648
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash25,564-15,513-7,9587,436-1,039